Benzeneacetic acid, a-hydroxy-a-phenyl-, (3-endo)-8-azabicyclo[3.2.1]oct-3-ylester

CAS : 16444-19-2

Ref. 3D-FB151764

Informations sur le produit

• Nom: Benzeneacetic acid, a-hydroxy-a-phenyl-, (3-endo)-8-azabicyclo[3.2.1]oct-3-ylester
• Synonymes: 1aH,5aH-Nortropan-3a-ol Benzilate, 1α<span class="text-smallcaps">H</smallcap>,5α<smallcap>H</span>-Nortropan-3α-ol, benzilate (ester), 8-Azabicyclo[3.2.1]Oct-3-Yl Hydroxy(Diphenyl)Acetate, Benzeneacetic acid, α-hydroxy-α-phenyl-, (3-endo)-8-azabicyclo[3.2.1]oct-3-yl ester, Benzeneacetic acid, α-hydroxy-α-phenyl-, 8-azabicyclo[3.2.1]oct-3-yl ester, endo-, Benzilic acid, 1α<span class="text-smallcaps">H</smallcap>,5α<smallcap>H</span>-nortropan-3α-yl ester, N-Desmethyl Tropan-3a-yl-(2-hydroxy-2,2-diphenyl)acetate, Nortropinyl benzilate, a-Hydroxy-a-phenylbenzeneacetic Acid (3-endo)-8-Azabicyclo[3.2.1]oct-3-yl Ester, 1αH,5αH-Nortropan-3α-ol, benzilate (ester), Norglipin, Benzilic acid, 1αH,5αH-nortropan-3α-yl ester

Description

Research has shown that benzeneacetic acid, a-hydroxy-a-phenyl-, (3-endo)-8-azabicyclo[3.2.1]oct-3-ylester has affinity for muscarinic acetylcholine receptors in the brain and spinal cord. The affinity of this ligand for these receptors is higher than that of acetylcholine. This compound is able to bind to the same receptors as acetylcholine, but with a higher efficiency. These properties make it an interesting candidate as a ligand in the development of new drugs to treat diseases related to the nervous system, such as Alzheimer's disease or Parkinson's disease.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 337.41 g/mol
• Formule: C₂₁H₂₃NO₃
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C21H23NO3/c23-20(25-19-13-17-11-12-18(14-19)22-17)21(24,15-7-3-1-4-8-15)16-9-5-2-6-10-16/h1-10,17-19,22,24H,11-14H2
• Code InChI: InChIKey=HIIVXBCWDPCZJA-UHFFFAOYSA-N
• SMILES: O=C(OC1CC2CCC(C1)N2)C(O)(c1ccccc1)c1ccccc1